GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (BOM:506820) » Definitions » Market Cap

AstraZeneca Pharma India (BOM:506820) Market Cap : ₹156,313 Mil (As of Jun. 10, 2024)


View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AstraZeneca Pharma India's share price for the quarter that ended in Mar. 2024 was ₹5320.4. AstraZeneca Pharma India's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 25 Mil. Therefore, AstraZeneca Pharma India's market cap for the quarter that ended in Mar. 2024 was ₹133,010 Mil.

AstraZeneca Pharma India's quarterly market cap increased from Sep. 2023 (₹112,603 Mil) to Dec. 2023 (₹137,996 Mil) but then declined from Dec. 2023 (₹137,996 Mil) to Mar. 2024 (₹133,010 Mil).

AstraZeneca Pharma India's annual market cap increased from Mar. 2022 (₹63,886 Mil) to Mar. 2023 (₹81,183 Mil) and increased from Mar. 2023 (₹81,183 Mil) to Mar. 2024 (₹133,010 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AstraZeneca Pharma India's Enterprise Value for Today is ₹151,121 Mil.


AstraZeneca Pharma India Market Cap Historical Data

The historical data trend for AstraZeneca Pharma India's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Pharma India Market Cap Chart

AstraZeneca Pharma India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59,788.75 75,255.00 63,886.25 81,182.50 133,010.00

AstraZeneca Pharma India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81,182.50 92,817.50 112,602.50 137,996.25 133,010.00

Competitive Comparison of AstraZeneca Pharma India's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, AstraZeneca Pharma India's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca Pharma India's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca Pharma India's Market Cap distribution charts can be found below:

* The bar in red indicates where AstraZeneca Pharma India's Market Cap falls into.



AstraZeneca Pharma India Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

AstraZeneca Pharma India's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹5320.4*25
=₹133,010

AstraZeneca Pharma India's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=₹5320.4*25
=₹133,010

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AstraZeneca Pharma India  (BOM:506820) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


AstraZeneca Pharma India Market Cap Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca Pharma India (BOM:506820) Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045
AstraZeneca Pharma India Ltd is engaged in the manufacture, distribution, and marketing of pharmaceutical products. Its only operating segment being Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation and Autoimmunity, Neuroscience and Infection and Vaccines.

AstraZeneca Pharma India (BOM:506820) Headlines

No Headlines